The University of Chicago Header Logo

Connection

Jon Grant to Hallucinogens

Back to Details
This is a "connection" page, showing publications Jon Grant has written about Hallucinogens.
Jon Grant
Connection Strength
0.830
Hallucinogens
  1. An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder. Clin Neuropharmacol. 2026 Jul-Aug 01; 49(4):163-169.
    View in: PubMed
    Score: 0.830
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.